ADMA
ADMA BIOLOGICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$9.11
+1.79%Forward multiples
Based on analyst estimates
- P/E forward
- 11.25x
- P/E 2026E
- 11.14x
- P/E 2027E
- 9.41x
- P/E 2028E
- 7.40x
- P/S forward
- 3.51x
Trailing multiples
Trailing twelve months
- P/E TTM
- 12.65x
- PEG TTM
- 0.99x
- Price / book
- 5.00x
- Price / sales
- 3.98x
- Price / cash flow
- 14.92x
Enterprise value
- Enterprise value
- $2.1B
- EV / sales
- 4.12x
- EV / EBITDA
- 8.98x
- EV / EBIT
- 9.74x
- Market cap
- $2.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026